Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Comment by rgonlyfactsplson May 25, 2011 9:14am
382 Views
Post# 18621926

RE: news

RE: news
dnd...if you are referring to the "made-in-Canada" article I believe this would fall under the category of "self promotion" helped along by an external publicist (firm).
 
Hence, news-based in this case, but with more commentary and background than a standard press release and more like a mini pre-written article for insertion in a newspaper or web site. Thus, no associated press release. I could be wrong but that's my guess. And, I would strongly support this "promotional" initiative (if that's what it is) and hope it is one of many articles and new "types" of initiatives we will soon see.
 
I have to believe Endo would still need to "sign-off" on this communication. Which then raises an additional question(s) as why we have not seen this (type and level) of related activity before (since Endo exercised its option for exclusive global rights)? Is the answer as simple as undervalued sp = greater need for more communication of all the very exciting things happening at Bioniche (Urocidin-specific as related to Endo)? Would Endo have been comfortable with this heightened communication before? Not sure.
 
Anyways, I like it....a lot! Have a good one, rg
Bullboard Posts